Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Tifcemalimab | TAB-004; JS-004 | Phase 3 Clinical | Shanghai Junshi Biosciences Co Ltd | Solid tumours; Head and Neck Neoplasms; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Small Cell Lung Carcinoma; Carcinoma, Transitional Cell; Hodgkin Disease; Pancreatic Neoplasms; Nasopharyngeal Carcinoma; Lymphoma; Lung Neoplasms; Esophageal Squamous Cell Carcinoma; Melanoma | Details |
ANB-032 | ANB-032 | Phase 2 Clinical | Anaptysbio Inc | Inflammation; Eczema; Dermatitis, Atopic | Details |
MB-272 | MB272; GS-0272 | Phase 1 Clinical | University Of Oxford, MiroBio Ltd | Autoimmune Diseases; Arthritis, Rheumatoid | Details |
Venanprubart | LY-3361237 | Phase 1 Clinical | Sanford-Burnham Medical Research Institute, Eli Lilly And Company | Sjogren's Syndrome; Lupus Erythematosus, Systemic; Psoriasis | Details |
HFB200604 AID | HFB-200604-AID; HFB200604; HFB-200604; HFB200604 AID | Phase 1 Clinical | HiFiBiO Therapeutics | Autoimmune Diseases; Inflammation | Details |
HFB-200603 | HFB-200603 | Phase 1 Clinical | HiFiBiO Therapeutics | Stomach Neoplasms; Carcinoma, Renal Cell; Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma | Details |
This web search service is supported by Google Inc.